Maternal Diabetes Driving Congenital Heart Disease Market Growth Driver: A Major Catalyst in the Evolution of the Congenital Heart Disease (CHD) Market in 2025

"What market dynamics are playing a key role in accelerating the growth of the congenital heart disease (chd) market?
The rise in maternal diabetes cases is expected to drive the growth of the congenital heart disease (CHD) market. Maternal diabetes, or gestational diabetes mellitus (GDM), develops during pregnancy in women without prior diabetes. It is linked to sedentary lifestyles, unhealthy eating, and higher obesity rates among women of childbearing age. This condition can lead to congenital heart disease in infants due to the high blood sugar levels, which disrupt fetal heart development. For example, the UK's National Health Service reported that adverse pregnancy outcomes for women with type 2 diabetes increased from 4.9% in 2021 to 6.6% in 2022. As such, the rising cases of maternal diabetes are contributing to the growth of the CHD market.

Get Your Congenital Heart Disease (CHD) Market Report Here:
https://www.thebusinessresearchcompany.com/report/congenital-heart-disease-chd-global-market-report

How will the growth rate of the congenital heart disease (chd) market shape industry trends by 2034?
The congenital heart disease (CHD) market has experienced rapid growth in recent years. It will rise from $4.42 billion in 2024 to $4.87 billion in 2025, at a compound annual growth rate (CAGR) of 10.1%. This growth is driven by the increasing prevalence of risk factors such as obesity and smoking, improved diagnostic technologies, the expanding geriatric population, awareness campaigns, enhanced reimbursement policies, and higher investments in research and development.

The congenital heart disease (CHD) market is projected to grow to $7.05 billion by 2029, with a CAGR of 9.7%. The growth is attributed to better access to healthcare in developing regions, innovations in cardiac imaging, early detection campaigns, increased healthcare spending, and personalized medicine. Trends include minimally invasive surgical techniques, telemedicine for remote monitoring, personalized treatments, advanced implantable devices, and AI/ML integration in diagnostics and therapy.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15545&type=smp

What trends are poised to drive the future success of the congenital heart disease (chd) market?
Companies in the congenital heart disease market are developing non-surgical heart valves to offer minimally invasive treatments. For example, in February 2023, Medtronic, a US-based medical technology company, reintroduced its Harmony Transcatheter Pulmonary Valve (TPV) System. This system provides a non-surgical alternative for patients with congenital heart disease, specifically for those with right ventricular outflow tract (RVOT) anomalies.

Which primary segments of the congenital heart disease (chd) market are driving growth and industry transformations?
The congenital heart disease (CHD) market covered in this report is segmented -

1) By Type: Heart Valve Defects, Heart Wall Defects, Blood Vessel Defects, Other Types
2) By Diagnosis: Electrocardiogram, Chest X-ray, Echocardiogram, Transesophageal Echocardiogram, Pulse Oximetry, Exercise Stress Test, Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI), Cardiac Catheterization, Other Diagnosis
3) By Treatment: Interventional Cardiology, Cardiac Surgery, Telemedicine, Medication Management, Lifestyle Modifications
4) By Age Group: Infants, Children, Adolescents, Adults
5) By Application: Hospitals And Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Research And Academic Institutions

Subsegments:
1) By Heart Valve Defects: Aortic Valve Stenosis, Pulmonary Valve Stenosis, Mitral Valve Prolapse, Tricuspid Valve Defects, Valve Regurgitation
2) By Heart Wall Defects: Atrial Septal Defect (ASD), Ventricular Septal Defect (VSD), Atrioventricular Septal Defect (AVSD), Hypoplastic Left Heart Syndrome (HLHS), Tetralogy of Fallot (TOF)
3) By Blood Vessel Defects: Coarctation Of The Aorta, Patent Ductus Arteriosus (PDA), Pulmonary Artery Stenosis, Transposition Of The Great Arteries (TGA), Truncus Arteriosus
4) By Other Types: Single Ventricle Defects, Ebstein's Anomaly, Total Anomalous Pulmonary Venous Return (TAPVR), Coronary Artery Anomalies, Pulmonary Venous Obstruction

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15545

Which geographical regions are pioneering growth in the congenital heart disease (chd) market?
North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the congenital heart disease (chd) market landscape?
Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15545&type=smp

What Is Covered In The Congenital Heart Disease (CHD) Global Market Report?

•Market Size Forecast: Examine the congenital heart disease (chd) market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the congenital heart disease (chd) market for a structured understanding.
•Key Players Overview: Analyze major players in the congenital heart disease (chd) market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the congenital heart disease (chd) market.
•Segment Contributions: Evaluate how different segments drive overall growth in the congenital heart disease (chd) market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the congenital heart disease (chd) market.
•Industry Challenges: Identify potential risks and obstacles affecting the congenital heart disease (chd) market.
•Competitive Landscape: Review strategic developments in the congenital heart disease (chd) market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.